참고문헌 (25)

1. Ekor, M. (2014). The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Frontiers in Pharmacology, 4, 177. https://doi.org/10.3389/fphar.2013.00177 

   상세보기

2. Lee, S. D. & Kwang, S. S. (1991). A toxicity study of herbal drugs. The Journal of Won Kwang Oriental Medicine, 1(1), 33-38. 

3. Cheon, C. H., Park, J. S., Park, S. J., Kwon, K. T., Shin, Y. C., & Ko, S. G. (2011). Necessity of adverse event reporting system through the trend of internet news about safety of herbal medicine. Korean Journal of Oriental Preventive Medical Society, 15(2), 131-143. 

4. Park, K., Lee, J., Choi, H. J., & Park, B. J. (2017). Establishing good safety and effectiveness evaluation system for globalization of herbal medicines. Korean Public Health Research, 43(1), 39-51. https://doi.org/10.22900/kphr.2017.43.1.004 

   

5. Kim, S. H., Kim, S. H., Park, C. B., Shim, Y. H., Park, S. H., Shin, S. H., et al. Eleutherococcus sessiliforus Seeman; 90 days repeated dose toxicity study (oral) in Rats. Osong: Biotoxtech Co. 2004:1-26. 

6. Ma, J. Y., Huang, D. S., Lee, N. H., Ha, H. K., Yu, Y. B., & Shin, H. K. (2008). Acute toxicity study on Sipjeondaebo-tang in rats. Korean Journal of Oriental Physiology & Pathology, 22(5), 1192-1195. 

7. Sanguinetti, M. C. & Tristani-Firouzi, M. (2006). hERG potassium channels and cardiac arrhythmia. Nature. 440(7083), 463-469. https://doi.org/10.1038/nature04710. 

   상세보기

8. Jung, W. J., Kim, H., Cha, Y. S., Kim, O. H., Cha, K. C., Lee, K. H., et al. (2012). Cardiac toxicities associated with herbal remedies. Journal of the Korean Society of Clinical Toxicology, 10(1), 1-7. 

9. Kim, H. T., Kim, H., Kim, O. H., Cha, Y. S., Cha, K. C., Lee, K. H., et al. (2012). Three cases of cardiac toxicity after intake of symplocarpus renifolius. Journal of the Korean Society of Clinical Toxicology, 10(1), 41-45. 

10. Hwang, J. Y. & Kim, H. (2015). Case report: a patient presenting with elevations of cardiac enzyme levels after Veratrum oxysepalum ingestion. Journal of the Korean Society of Clinical Toxicology, 13(2), 111-116. 

11. Kratz, J. M., Grienke, U., Scheel, O., Mann, S. A., & Rollinger, J. M. (2017). Natural products modulating the hERG channel: hearthaches and hop. Natural Product Reports, 34(8), 957-80. https://doi.org/10.1039/c7np00014f 

    상세보기

12. Sohn, Y. W. Guidelines for cardiovascular pharmacology testing. Osong: National institute of food and drug safety evaluation. 2016:1-58. 

13. Lee, S. H. Clinical safety guidelines for cardiovascular system. Osong: National institute of food and drug safety evaluation. 2015:1-31. 

14. Choi, S., Kwon, O. B., Lee, S., Seo, C. S., & Shin, H. K. (2019). Cardiac safety assessment of medicinal herbal formulas using hERG-HEK 293 cell. Journal of Korean Medicine, 40(2), 94-105. https://doi.org/10.13048/jkm.19020 

    원문보기 상세보기

15. Ha, H., Lee, S., Kim, D. H., Seo, C. S., & Shin, H. K. (2021). hERG channel-related cardiotoxicity assessment of 13 herbal medicines. Journal of Korean Medicine, 42(3), 44-55. http://dx.doi.org/10.13048/jkm.21024 

    원문보기 상세보기

16. Kalyaanamoorthy, S. & Barakat, K. H. (2018). Development of safe drugs: the hERG challenge. Medicinal Research Reviews. 38(2), 525-555. https://doi.org/10.1002/med.21445 

    상세보기

17. Recanatini, M., Poluzzi, E., Masetti, M., Cavalli, A., & De Ponti, F. (2005). QT prolongation through hERG K + channel blockade: current knowledge and strategies for the early prediction during drug development. Medicinal Research Reviews, 25(2), 133-166. https://doi.org/10.1002/med.20019 

    상세보기

18. The International Council for Harmonisation. The non-clinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pahrmaceuticals. 2005: 1-14. (https://www.ema.europa.eu/en/ich-s7b-non-clinical-evaluation-potential-delayed-ventricular-repolarization-qt-interval) 

19. Baburin, I., Varkevisser, R., Schramm, A., Saxena, P., Beyl, S., Szkokan, P., et al. (2018). Dehydroevodiamine and hortiamine, alkaloids from the traditional Chinese herbal drug Evodia rutaecarpa, are IKr blockers with proarrhythmic effects in vitro and in vivo. Pharmacological Research, 131, 150-163. https://doi.org/10.1016/j.phrs.2018.02.024 

    상세보기

20. Lee, H. Y. & Kim, C. W. (1999). Isolation and quantitative determination of berberine and coptisine from tubers of Corydalis ternate. Korean Journal of Pharmacognosy, 30(3), 332-334. https://www.koreascience.or.kr/article/JAKO199903041280083.pdf 

21. Orvos, P., Virag, L., Talosi, L., Hajdu, Z., Csupor, D., Jedlinszki, N., et al. (2015). Effects of Chelidonium majus extracts and major alkaloids on hERG potassium channels and on dog cardiac action potential - a safety approach. Fitoterapia, 100, 156-165. https://doi.org/10.1016/j.fitote.2014.11.023 

    상세보기

22. Lin, K., Liu, Y. Q., Xu, B., Gao, J. L., Fu, Y. C., Chen, Y., et al. (2013). Allocryptopine and benzyltetrahydropalmatine block hERG potassium channels expressed in HEK293 cells. Acta Pharmacologica Sinca. 34(6), 847-858. https://doi.org/10.1038/aps.2012.176 

    상세보기

23. Kratz, J. M., Grienke, U., Scheel, O., Mann, S. A., Rollinger, J. M. (2017). Natural products modulating the hERG channel: heartaches and hope. Nat Prod Rep. 34(8), 957-980. https://doi.org/10.1039/c7np00014f 

    상세보기

24. Schramm, A., Baburin, I., Hering, S., & Hamburger, M. (2011). hERG channel inhibitors in extracts of Coptidis rhizoma. Planta Medica, 77(7), 692-697. https://doi.org/10.1055/s-0030-1270920 

    상세보기

25. Neag, M. A., Mocan, A., Echeverria, J., Pop, R. M., Bocsan, C. I., Crisan, G., Buzoianu, A. D. (2018). Berberine: Botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders. Frontiers in Pharmacology, 9, 557. https://doi.org/10.3389/fphar.2018.00557 

    상세보기

저자의 다른 논문 :

하혜경 (99) 진성은 (13) 서창섭 (112) 신현규 (213)